Anagenics Ltd has released a press release.
Cellmids Shipment of SARS-CoV-2 Tests Received
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Anagenics
- Reinstatement to Official Quotation
- Response to ASX Query Letter
- Market Update on COVID-19
- Appendix 4D, Half Year Accounts and Presentation
- Cellmids Evolis Patent to be Granted in China
Later from Anagenics
- Independent Test Results For The Wondfo SARS-CoV-2 Test
- Cellmids Alopecia Patent Allowed in Australia and Japan
- Appointment of Dr Dominic Burg as Chief Operating Officer
- CDY signs Introducer Agreement to broaden product offering
- Cellmid Reports on Results of The Doherty Institute Testing
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics